R
ReShape Lifesciences D
D
RSLS
2.84000
USD
0.32
(12.70%)
مغلق
حجم التداول
16,630
الربح لكل سهم
-17
العائد الربحي
-
P/E
0
حجم السوق
3,781,051
الأخبار المقالات
العنوان: ReShape Lifesciences Inc.
القطاع: Healthcare
الصناعة: Medical Devices
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.